These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9723640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb 13; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract] [Full Text] [Related]

  • 5. Inclusion of lipoprotein subfractions among efficacy parameters.
    Superko HR.
    Am J Cardiol; 1998 Apr 23; 81(8A):52F-55F. PubMed ID: 9604909
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of cardiovascular events by hypolipidemic therapy evidence-based medicine criteria.
    Heller FR.
    Acta Clin Belg; 1999 Oct 23; 54(5):299-301. PubMed ID: 10555389
    [Abstract] [Full Text] [Related]

  • 11. Cholesterol-lowering studies for aortic stenosis.
    Rosenbluth A, Fuster V.
    Adv Cardiol; 2004 Oct 23; 41():62-74. PubMed ID: 15285219
    [No Abstract] [Full Text] [Related]

  • 12. Hyperlipidemia and its management in renal disease.
    Massy ZA, Kasiske BL.
    Curr Opin Nephrol Hypertens; 1996 Mar 23; 5(2):141-6. PubMed ID: 8744535
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. One great leap for lipid lowering drugs.
    Cardiovasc J S Afr; 2002 Mar 23; 13(5):265-6. PubMed ID: 12557874
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T.
    Nihon Rinsho; 2006 Nov 23; 64(11):2113-8. PubMed ID: 17087305
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones.
    Florkowski CM.
    Am J Cardiovasc Drugs; 2002 Nov 23; 2(1):15-21. PubMed ID: 14727995
    [Abstract] [Full Text] [Related]

  • 20. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E, Ogawa H, Koyanagi R, Arashi H, Yamaguchi J, Matsui K, Hagiwara N.
    J Cardiol; 2017 Mar 23; 69(3):536-541. PubMed ID: 27349705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.